Entry |
|
Name |
Interferon alfacon-1 (USAN/INN); Interferon alfacon-1 (genetical recombination) (JAN); Advaferon (TN); Infergen (TN) |
Abbr |
CIFN |
Formula |
C870H1366N236O259S9
|
Exact mass |
19551.846
|
Mol weight |
19564.1658
|
Class |
Immunological agent
DG01752 Interferone
|
Remark |
|
Efficacy |
Antiviral, Biological response modifier |
Target |
|
Pathway |
hsa04060 | Cytokine-cytokine receptor interaction |
hsa04620 | Toll-like receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AB Interferons
L03AB09 Interferon alfacon-1
D02744 Interferon alfacon-1 (USAN/INN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AD Antivirals
S01AD05 Interferon
D02744 Interferon alfacon-1 (USAN/INN)
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
D02744 Interferon alfacon-1
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interferon receptors
IFNAR1
D02744 Interferon alfacon-1 (USAN/INN)
IFNAR2
D02744 Interferon alfacon-1 (USAN/INN)
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Interferon
D02744 Interferon alfacon-1 (USAN/INN)
Antimicrobials abbreviations [BR:br08327]
Antivirals
Entry, fusion or uncoating inhibitor
Interferon
D02744 Interferon alfacon-1 (USAN/INN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02744
|
Other DBs |
|
LinkDB |
|